Note: Descriptions are shown in the official language in which they were submitted.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
1
Plant transformation method
Description
The present invention relates to a method of producing a transgenic plant.
Said method
comprises, inter alia, the steps of a) providing a wounded transformable
explant comprising a
hypocotyl or a portion thereof, at least one cotyledon and wounded tissue, b)
transforming cells
comprised by said explant, and c) transferring said explant to a growing
medium, comprising at
least one selection compound for a selectable marker. Moreover, the present
invention relates
to a plant obtainable by the method according to the present invention.
Agrobacterium-mediated plant transformation, first described for tobacco in
1984, is now widely
used for introduction of genes into plants for purposes of basic research as
well as for
generation of commercially used transgenic crops. Plants which can be
successfully
transformed include most major economic crops, vegetables, ornamental,
medicinal, fruit, tree,
and pasture plants.
Plant transformation is mostly done by Agrobacterium-mediated plant
transformation.
Agrobacterium is a naturally occurring pathogenic soil bacterium which is
capable of transferring
DNA into the genome of plant cells. For Agrobacterium-mediated plant
transformation, the gene
of interest is placed between the left and right border repeats of
Agrobacterium T-DNA (transfer
DNA). Afterwards, the T-DNA region containing the gene of interest is stably
integrated into the
plant genome by using an appropriate plant transformation protocol (for a
review see Gelvin,
2003 Microbiol Mol Biol Rev. 67(1): 16-37).
Aside from Agrobacterium-mediated plant transformation, other plant
transformation methods
exist such as viral transformation, electroporation of plant protoplasts, and
particle
bombardment.
Generally, plant transformation techniques are based on the same principles.
In a first step, the
gene of interest is introduced in a suitable transformation vector. The
transformation vector
harbouring the gene of interest is then introduced into regenerable cells of a
target plant. Since
only a minor proportion of target cells receive the gene of interest,
selection for transformed
plant cells among a large excess of untransformed cells is carried out.
Moreover, once the gene
of interest has been stably introduced into the genome of a host cell, it is
essential to establish
regeneration conditions in order to regenerate whole plants from a single
transformed plant cell
(see, e.g., Birch, 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol. 48: 297-
326).
One of the simplest available Agrobacterium-based plant transformation methods
is "Floral Dip
Transformation". Floral Dip is a germline transformation method by which the
gene of interest is
transformed into cells that give rise to the seeds. This method involves
dipping plants (in early
flowering stage) in a suspension of Agrobacterium cells (Clough and Bent,
1998, Plant J
16:735-43). A few weeks after dipping, seeds of dipped plants are collected,
and the seed
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
2
population is selected for transformants. The advantage of Floral Dip
transformation technique
is that it avoids the use of tissue culture and plant regeneration which is
cost-intensive and
requires trained personnel. Unfortunately, small plant size, short generation
time, and a large
amount of seeds per plant are prerequisites for Floral Dip. Consequently, this
transformation
method has only been successfully applied to a few species, mainly for
Arabidopsis thaliana
(but also with Medicago truncatula and Brassica, see Wang et al 2003. Plant
Cell Reports 22:
274-281).
Regeneration of whole transformed plants which are recalcitrant to germline
transformation is
considered as the bottleneck in plant transformation since regeneration is
difficult to achieve,
time-consuming, and requires specific equipment.
The first steps of plant regeneration are usually carried out under in vitro
conditions, i. e. on a
specific nutrient medium under sterile conditions. After transformation of
target cells, cell
division is induced by specific plant hormones in order to grow a callus from
a transformed plant
cell. After callus induction, the resulting callus is transferred to a medium
allowing shoot
induction. The callus is incubated (under in vitro conditions) on said medium
until shoots are
formed. After shoot formation, the shoot is transferred to a medium that
allows for root formation
(under in vitro conditions). After root formation, regenerated plantlets (i.e.
shoots with roots) are
usually transferred from in vitro conditions to ex vitro conditions, mostly to
soil under
greenhouse conditions. Thus, callus induction, shoot induction and root
induction are usually
carried out under in vitro conditions.
The current methods for regenerating plants under in vitro conditions,
however, have some
disadvantages. Regenerating whole plants under in vitro conditions is
expensive and requires
specific nutrient media, specific equipment and trained personnel. There is,
of course, always
the risk of contamination (e.g. contamination with fungus). If a tissue
culture gets contaminated,
the work of weeks or even of months may become worthless.
Without tissue culture, however, plant transformation is challenging since
tissue culture
a) allows for selection of transgenic plant cells (and plant shoots,
respectively) and
b) simultaneously suppresses growth of bacterial and fungal microorganisms.
Without selection,
it is difficult to identify plant cells, plant shoots, or plantlets (i.e.
plants with shoots and roots)
which carry the transgene.
Moreover, the regeneration of transgenic plants is generally a labor-intensive
and very time-
consuming task. For example, time needed from the isolation of putative
transgenic in-vitro
Brassica or Brachypodium shoots to ex-vitro adapted, greenhouse ready plants
takes 12 weeks
to 14 weeks (see e.g. for Brachypodium: Bablak et al (1995) Plant Cell, Tissue
and Organ
Culture 42: 97-107; or Christiansen et al. (2005) Plant Cell Report 23: 751-
758; for Brassica:
Cardoza and Stewart (2004), Transgenic crops of the World-Essential Protocols,
379-387; or
Jonoubi et al. (2005).Biologia Plantarum 49 (2): 175-180).
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
3
Transformation procedures that avoid tissue culture or reduce tissue culture
would be valuable,
especially for plants which are difficult to regenerate. Scientists have
attempted to develop plant
transformation procedures that do not require tissue culture, but these
attempts have been met
with limited success. For example, Graves and Goldman (1986 Plant Mol. Biol.
7: 43-50)
reported that Agrobacterium could infect mesocotyl cells of germinating corn
seeds, but the
resulting transformed plants were chimeras and the transformation efficiency
was extremely
poor.
The soybean (Glycine max) belongs to the Fabaceae (Leguminosae) family. This
plant family is
identified by having its seed borne in a legume (pod). The soybean is thought
to have originated
in China. Wild types of soybeans are viny in nature, which probably is a major
reason why
soybeans were first introduced in the United States as a hay crop.
Introductions from China,
Manchuria, Korea and Japan have been important in developing varieties for the
United States.
Modern breeding efforts to improve the agronomic traits, such as more erect
growth, reduced
lodging and increased seed size, have been primarily responsible for the
development of
soybeans into a crop of world-wide importance. The acreage and the proportion
of the crop
harvested for grain has increased steadily and today soybeans are a major
world commodity.
With respect to soybean transformation, methods are known which are based on
somatic
embryogenesis: Embryos are induced from immature soybean cotyledons by placing
the
explant on high levels of 2,4-D (40 mg/L) and the embryogenic tissues are
subsequently
proliferated on induction medium (Finer (1988) Plant Cell Rep 7:238-241) or
liquid suspension
culture (Finer and Nagasawa (1988) Plant Cell Tissue Organ Cult 15:125-136).
Hinchee et al. describes the production of transgenic soybean plants via
Agrobacterium-
mediated transformation . The production of transgenic plants is based on a
regeneration
protocol in which shoot organogenesis is induced on cotyledons of soybeans
(see Hinchee et
al. (1988) Nature Biotechnology, 6:915-922).
Also known are methods based on Agrobacterium-mediated transformation of
zygotic immature
cotyledons (Parrott et al. (1989) Plant Cell Rep 7:615-617; Yan et al. (2000)
Plant Cell Rep
19:1090-1097; Ko et al. (2003) Theor Appl Genet. 107:439-447). However, in
Parrott et al. the
three plants produced were chimeric, from a multicellular origin, and did not
transmit the
transgene to the next generation. Yan et al. (2000) Plant Cell Rep 19:1090-
1097 reported a low
transformation frequency of 0.03%. The plant produced transmitted the
transgene into the next
generation, presumably due to the continuous selection of transformed primary
embryos for the
production of secondary embryos thereby resulting in non-chimeric plants.
Recently, Ko et al.
(2003) Theor Appl Genet. 107:439-447 has reported the recovery of transgenic
plants at 1.7%
transformation frequencies, however, the method relies on using a partially
disarmed
(oncogenic) Agrobacterium strain, pKYRT, with a functional TR-DNA sequence in
order to
stimulate embryogenesis (Ko et al. (2004) Planta 218:536-541). These methods
use the
immature cotyledons as the target tissue with subsequent proliferation and
selection on solid
medium.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
4
US2009/0049567 discloses Agrobacterium-mediated soybean transformation
utilizing
meristematic cells of primary or higher leaf nodes as target tissues and
subsequent
regeneration of the transformed cells into a whole plant.
CN101736028A describes a method for the transformation of soybean independent
of tissue
culture by transforming the cotyledonary node. Soybean seeds are germinated in
vitro or in the
fields. After 5 to 7 days, the apical meristem and the meristem are removed
from the seedlings.
Subsequently the cotyledonary node area was transformed by Agrobacterium
mediated
transformation. After 10 to 15 days the leaves were brushed with a selection
compound. The
disclosed method however only yielded a relatively low number of transgenic
plants (e.g. 127
seedlings were transformed, only 8 transgenic plants were obtained).
Weeks et al. (Transgenic Research (2008), 17, 587-597) describes a method for
transforming
alfalfa plants. For the transformation, young seedlings were cut at the apical
node and
vigorously vortexed in an Agrobacterium suspension containing an abrasive
medium. No
selectable marker gene was used in the described method. Therefore,
transformation was
monitored via PCR and/or histochemic analysis. However, a large number of the
regenerated
plants were chimeric.
W000/56904 describes a process for selecting transgenic meristematic cells in
cotton, coffee,
cocoa, banana or grape plants and the consequent production of transgenic
plants. The
process comprises the steps of introducing exogenous genes into cells of the
apical meristem of
embryonic axes or tissues or organs containing meristems of cotton, coffee,
cocoa, banana or
grape plants; induction of multiple shooting of the cells in the apical
meristematic region
modified in the preceding step by cultivating their embryonic axes or tissues
containing
meristems in a medium comprising a multiple shooting inducer; and selecting
the transgenic
meristematic cells of the apical region by further cultivation of said
meristems in a medium
containing a molecule which translocate and concentrates in the apical
meristematic of
embryonic axes of cotton, coffee, cocoa, banana or grape plants.
WO 99/18223 discloses a process for producing transgenic leguminous plants
containing
exogenous DNA, which comprises the steps of introducing exogenous genes into
cells of the
apical meristem of embryonic axis of leguminous plants by the biobalistic
method; inducing
multiple shooting of the cells in the apical meristematic region modified in
the preceding step by
cultivating their embryonic axis in a medium containing a multiple shooting
inducer; and
selecting the meristematic cells of the apical region, transformed by further
cultivation of said
embryonic axis in a medium containing a molecule which concentrates in the
apical
meristematic region of said leguminous plants embryos.
Aragao et al. discloses the transformation of Phaseolus vulgaris by biolistic
transformation
(Aragao FJL, Barros LMG, Brasileiro ACM, Ribeiro SG, Smith FD, Sanford JC,
Faria JC, Rech
EL (1996) Inheritance of foreign genes in transgenic bean (Phaseolus vulgaris
L.) co-
transformed via particle bombardment. Theor. Appl. Genet. 93:142-150.). In a
further paper,
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
Aragao describes a method to obtain a high frequency of fertile transgenic
soybean plants
(Aragao FJL, Sarokin L, Vianna GR, Rech EL (2000) Selection of transgenic
meristematic cells
utilizing an herbicidal molecule results in the recovery of fertile transgenic
soybean [Glycine max
(L.) Merril] plants at high frequency. Theor. Appl. Genet. 101:1-6).
5
WO 97/23126 discloses a process for the micropropagation of shoots, rooted
shoots or
seedlings of a woody plant, which comprises cultivating the shoots, rooted
shoots or seedlings
in an oxygenated liquid medium, the shoots, rooted shoots or seedlings being
submerged in the
liquid medium.
W09407356 discloses a method of transforming pomaceous fruit scion or
rootstock cultivars
with Agrobacterium tumefaciens.
Although significant advances have been made in the field of Agrobacterium-
mediated
transformation methods, a need continues to exist for improved methods to
facilitate the ease,
speed and efficiency of such methods for transformation of plants. Therefore,
it was the
objective of the present invention to provide an improved method having higher
overall
efficiency in the process of generation of transgenic soybean plants. This
objective is solved by
the present invention.
Accordingly, the present invention relates to a method for producing a
transgenic plant,
comprising the steps of
a) providing a wounded transformable explant, comprising a hypocotyl or a
portion
thereof, at least one cotyledon, and wounded tissue selected from
i. wounded meristematic tissue of a primary or higher leaf node (in
particular
wounded axillary meristematic tissue of a primary or higher leaf node),
ii. wounded meristematic tissue of the cotyledonary node, and
iii. wounded epicotyl tissue
b) transforming cells comprised by the said explant with a polynucleotide
comprising at
least one plant expression cassette for a selectable marker gene,
c) transferring said explant to a growing medium by inserting the hypocotyl,
or a portion
thereof, of said explant into said growing medium, comprising at least one
selection
compound for said selectable marker gene,
d) allowing said explant to form a shoot, and/or allowing the shoot to
elongate, said shoot
comprising plant cells comprising said least one plant expression cassette for
said
selectable marker gene, and
e) regenerating a transgenic plant from said shoot.
In the context of the method of the present invention, a transgenic plant
shall be produced. The
term "transgenic" as used herein, preferably, refers to a cell or plant that
has incorporated
exogenous DNA sequences. Preferably, said exogenous DNA sequences are stably
incorporated into the genome of the transgenic plant or plant cell.
Preferably, said exogenous
DNA sequences comprise at least one polynucleotide comprising at least one
plant expression
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
6
cassette for a selectable marker gene. Preferably, the expression of the
selectable marker gene
is regulated by a promoter which allows for expression of said gene in the
plant. Such
promoters are well known in the art and, preferably, include constitutive
promoters, inducible
promoters, tissue specific promoters, and development specific promoters.
Preferred promoters
are e.g. disclosed in US2009/0049567 which herewith is incorporated by
reference with respect
to its entire disclosure content. The most preferred promoters for the
expression of the
selectable marker gene are constitutive promoters.
Preferably, the at least one polynucleotide comprising at least one plant
expression cassette for
a selectable marker gene is not normally present in the plant or plant cell,
or is normally present
at a different position in the genome of the plant or plant cell. Preferably,
the polynucleotide
comprising at least one plant expression cassette for a selectable marker gene
further
comprises a plant expression cassette for an agronomically valuable trait.
The plant to be transformed may be a monocotyledonous plant. Most preferably,
the plant to be
transformed is a dicotyledonous plant.
Preferably, the dicotyledonous plant is a plant of the family Fabaceae,
Solanaceae,
Brassicaceae, Chenopodiaceae, Asteraceae, Malvaceae, Linacea, Euphorbiaceae,
Convolvulaceae Rosaceae, Cucurbitaceae, Theaceae, Rubiaceae, Sterculiaceae or
Citrus. It is
particularly preferred that the plant is of the family Fabaceae, Solanaceae or
Brassicaceae.
If the plant is of the family Fabaceae, the plant is, preferably, of the genus
Glycine, Pisum,
Arachis, Cicer, Vicia, Phaseolus, Lupinus, Medicago or Lens. Preferred species
of the family
Fabaceae are Medicago truncatula, Medicago sativa, Glycine max, Glycine soja,
Pisum
sativum, Archis hypogea, Cicer arietinum, Vicia faba, Phaseolus vulgaris,
Phaseolus acutifolius,
Lupinus albus, Lupinus luteus, Lupinus angustifolius or Lens culinaris. More
preferred are the
species Glycine max, Archis hypogea and Medicago sativa. The most preferred
species is
Glycine max. Preferred genotypes of G. max are the genotypes used in the
Examples.
When the plant is of the family Solanaceae, the preferred genus is Solanum,
Lycopersicon,
Nicotiana or Capsicum. Preferred species of the family Solanaceae are S.
tuberosum, L.
esculentum (also known as Solanum lycopersicon), N. tabaccum or C. chinense.
More
preferred is S. tuberosum.
When the plant is of the family Chenopodiaceae, the preferred genus is Beta or
Spinacia
Preferred species are B. vulgaris and S. oleracea.
When the plant is of the family Asteraceae, the preferred genus is Helianthus
and the preferred
species is H. annuus.
In one preferred embodiment the plant is of the family Brassicaceae. If the
plant is of the family
Brassicaceae, the plant is, preferably, of the genus Brassica or Raphanus.
Preferred species of
the genus of the genus Brassica are the species B. napus, B. oleracea, B.
juncea or B. rapa.
Most preferred is the species B. napus.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
7
When the plant is of the family Malvaceae, the preferred genus is Gossypium or
Abelmoschus.
When the genus is Gossypium, the preferred species is G. hirsutum or G.
barbadense. The
most preferred species is G. hirsutum. A preferred species of the genus
Abelmoschus is the
species A. esculentus.
When the plant is of the family Linacea, the preferred genus is Linum. The
preferred species is
L. usitatissimum.
When the plant is of the family Euphorbiaceae, the preferred genus is Manihot,
Jatropha or
Rhizinus and the preferred species is M. esculenta, J. curcas or R. communis.
When the plant is of the family Convolvulaceae, the preferred genus is lpomea.
The preferred
species is I. batatas.
Particularly preferred plant species are Medicago truncatula, Medicago sativa,
Glycine max,
Glycine soja, Pisum sativum, Archis hypogea, Cicer arietinum, Lupinus albus,
Lupinus luteus,
Lupinus angustifolius, P. acutifolius and P vulgaris. More preferred are the
species Glycine max,
Archis hypogeal, and P vulgaris and Medicago sativa. The most preferred
species is Glycine
max.
The wounded transformable explant to be used in the method of the present
invention shall
comprise at least one cotyledon, and wounded tissue selected from wounded
meristematic
tissue of a primary or higher leaf node, wounded meristematic tissue of the
cotyledonary node,
and wounded epicotyl tissue. In a preferred embodiment, the wounded
transformable explant
further comprises a hypocotyl or a portion thereof.
In the context of the method of the present invention, the wounded
transformable explant is,
preferably, derived/obtained from a seedling.
Preferably, the seedling is a 3 to 20 days old seedling. More preferably, said
seedling is a 5 to
12 days old seedling. Even more preferably, it is a 4 to 12 days old seeding,
or a 6 to 10 days
old seedling. Most preferably, said seedling is a 7 to 8 days old seedling.
Preferably, the age of
a seedling is calculated from the germination of the seedling.
It is particularly contemplated that the seedling has been grown under in
vitro conditions, i.e.
under sterile conditions. However, it is also contemplated that the seedling
has been grown
under non-sterile conditions.
In the context of the method of the present invention, the wounded
transformable explant is,
preferably, obtained from a seedling by wounding said seedling i) in the
meristematic tissue of a
primary or higher leaf node, ii) in the meristematic tissue of the
cotyledonary node, or iii) in the
epicotyl region. Preferably, the wounded tissue is the target tissue of the
transformation, i.e.
cells comprised by the target tissue are transformed with the polynucleotide
comprising at least
one plant expression cassette for a selectable marker gene.
CA 02840550 2013-12-27
WO 2013/014585 PCT/1B2012/053705
8
Thus, in case meristematic tissue of the cotyledonary node is wounded, the
target tissue is
meristematic tissue of the cotyledonary node. In case meristematic tissue of a
primary or higher
leaf node is wounded, the target tissue is meristematic tissue of a primary or
higher leaf node.
In case epicotyl tissue is wounded, the target tissue is epicotyl tissue,
preferably the tissue at
which the epicotyl tissue has been wounded.
The terms "meristematic cells" or "meristematic tissue" are known by the
skilled person. The
term, preferably, refers to undifferentiated plant cells or tissue which
continually divides and
forms cells.
Preferably, the wounded meristematic tissue of the primary or higher leaf node
is wounded
apical meristematic tissue. More preferably, the wounded meristematic tissue
of the primary or
higher leaf node is wounded axillary meristematic tissue. Thus, the target
tissue is, preferably,
axillary meristematic tissue of a primary or higher leaf node.
The term "epicotyl" as used herein, preferably, refers to the portion of a
plant located between
cotyledonary node and primary leaf node.
Many methods of wounding can be used. Preferred methods are cutting, abrading,
piercing,
poking, penetration with fine particles or pressurized fluids, plasma
wounding, application of
hyperbaric pressure, or sonication. Wounding can be performed using objects
such as scalpels,
scissors, needles, abrasive objects, particles, electric gene guns, or sound
waves.
In the context of the method of the present invention, wounding is preferably
achieved by cutting
the seedling i) in the meristematic tissue of the cotyledonary node, ii) in
the epicotyl region, or
iii) in the meristematic tissue of a primary or higher leaf node (depending on
the target tissue).
More preferably, said wounding is achieved by decapitating said seedling at
the meristematic
tissue of the cotyledonary node, within the epicotyl region, or within the
meristematic tissue of a
primary or higher leaf node.
The portion of the plant below the cut is used as the transformable explant.
Thus, the parts of
the seedling that are located above the cut, are preferably removed.
Moreover, it is also particularly envisaged that the following parts are
removed from the seedling
in order to obtain the wounded transformable explant:
i. the roots,
ii. the roots and a portion of the hypocotyl,
iii. in case the explant is prepared from a dicotyledonous plant (which are
the most
preferred plants), one cotyledon is, preferably, removed.
The term "hypocotyl" as used herein, preferably, refers to the part of the
seedling between the
cotyledon(s) and the root. The use of a hypocotyl or portion thereof is
advantageous since the
hypocotyl can be inserted in the growing medium in step c) of the method of
the present
invention. Thereby, the explant can be better kept in an upward position.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
9
It is particularly preferred that at least two thirds of the hypocotyl, and,
more preferably, at least
one third, or even more preferably, one tenth of the hypocotyl (as comprised
by the seedling)
remain(s) attached to the wounded transformable explant. Even more preferably,
0.5 to 2 cm, or
0.5 to 1 cm of the hypocotyl remain(s) attached to the explant. It is further
contemplated 0.1 to 2
cm of the hypocotyl remain(s) attached to the explant.
Accordingly, the portion of the hypocotyl comprised by the wounded
transformable explant
comprises, preferably, at least two thirds, at least one third, or at least
one tenth of the
hypocotyl as comprised by the seedling. Also preferably, said portion
comprises 0.5 to 2 cm, 0.5
to 1 cm, or 0.1 to 2 cm of the hypocotyl as comprised by the seedling.
Moreover, it is also
envisaged that the portion of the hypocotyl is less than one third, less than
one fifth, or in
particular, less than one tenth of the hypocotyl as comprised by the seedling.
Thus, the portion
of the hypocotyl, preferably, has a length of at least 0.2, 0.4, or 0.5 cm.
However, if the target
tissue is wounded meristematic tissue of a primary or higher leaf node, the
hypocotyl may be
completely removed from the plant. In this case, the explant to be transformed
does not
comprise hypocotyl tissue.
Preferably, if the seedling is wounded at the meristematic tissue of the
cotyledonary node (e.g.
by cutting or decapitating), the meristematic tissue of the cotyledonary node,
or a portion
thereof, remains attached to the transformable explant.
Thus, in a preferred embodiment of the method of the present invention, the
wounded
transformable explant derived from a seedling comprises:
i. a hypocotyl or a portion thereof,
ii. at least one cotyledon,
iii. wounded meristematic tissue of the cotyledonary node.
Preferably, if the seedling is wounded at the epicotyl (e.g. by cutting or
decapitating, see
above), a portion of the wounded epicotyl remains attached to the
transformable explant. The
epicotyl may be wounded at any position.
Thus, in another preferred embodiment the wounded transformable explant
derived from a
seedling comprises:
i. a hypocotyl or a portion thereof,
ii. at least one cotyledon, and
iii. wounded epicotyl tissue.
Preferably, if the seedling is wounded at the meristematic tissue of a primary
or higher leaf
node, a portion of the wounded tissue is attached to the transformable
explant.
Thus, in a preferred embodiment of the method of the present invention, the
wounded
transformable explant derived from a seedling comprises:
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
i. the hypocotyl or a portion thereof,
ii. at least one cotyledon,
iii the epicotyl, and
iv. wounded meristematic tissue of a primary or higher leaf node.
5
In step b) of the method of the present invention, cells comprised by the said
explant shall be
transformed with a polynucleotide comprising at least one plant expression
cassette for a
selectable marker gene.
10 The polynucleotide to be transformed shall comprise at least one plant
expression cassette for a
selectable marker gene.
The term "selectable marker gene" as used herein, refers to a gene that - in
the presence of the
corresponding selection compound (herein also referred to as the "selection
compound for the
selectable marker gene") in the growing medium- confers a growth advantage to
a plant or plant
cell transformed with a plant expression cassette for said selectable marker
as compared to a
plant or plant cell not been transformed with said plant expression cassette
and which, thus,
does not comprise the selectable marker gene. Preferably, the selectable
marker gene and/or
plant expression cassette for said marker gene is heterologous to the plant to
be transformed,
and thus is not naturally present in the plant to be transformed.
Preferably, the selectable marker gene is a negative selection marker gene.
Negative selection
marker genes confer a resistance and/or increased tolerance to a selection
compound.
Preferred selection compounds are herbicides.
In the context of the method of the present invention, the selection compound,
preferably, is
capable of being transported from the growing medium to the cells which have
been
transformed with the polynucleotide comprising at least one plant expression
cassette for the
selectable marker gene (thus, the marker gene that corresponds to the
selection compound),
and/or to cells which are derived from said cell (by cell division). Thus, the
selection compound
preferably is capable of being transported from the growing medium to the
transformed
cells/tissue comprising said polynucleotide. Preferably, the transport is
through the vascular
bundles of the explant, in particular through the phloem or xylem.
Particularly preferred
selection compounds that are capable of being transported through the explant
are
imidazolinone herbicides (see below) and D-amino acids, in particular D-
alanine and D-serine,
or herbicides having similarity to amino acids, like phosphinothricin, or
glyphosate.
Accordingly, marker genes which may also be employed in the invention are for
example, but
not excluding others:
- Phosphinothricin acetyltransferases (PAT; also named Bialaphoeresistance;
bar; De Block et
al. (1987) Plant Physiol 91:694-701; EP 0 333 033; US4,975,374)
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
11
- 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS; U55,633,435) or
glyphosate
oxidoreductase gene (US5,463,175) conferring resistance to Glyphosate TM (N-
(phosphonomethyl)glycine) (Shah ef al. (1986) Science 233: 478)
- Glyphosate TM degrading enzymes (GlyphosateTM oxidoreductase; gox),
- Sulfonylurea- and imidazolinone-inactivating acetolactate synthases (for
example mutated
ALS variants with, for example, the S4 and/or Hra mutation
- Bromoxynil TM degrading nitrilases (bxn)
- Kanamycin- or. G418- resistance genes (NPTII; NPTI) coding e.g., for
neomycin
phosphotransferases (Fraley et al. (1983) Proc Natl Aced Sci USA 80:4803),
which expresses
an enzyme conferring resistance to the antibiotic kanamycin and the related
antibiotics
neomycin, paromomycin, gentamicin, and G418,
Dicamba degrading enzymes (0-demethylase, oxygenase, ferredoxin) (Behrens et
al. 2007
Science 316:1185-1188; U57022896)
- marker genes that confer resistance against the toxic effects imposed by D-
amino acids like
e.g., D-alanine and D-serine (W003/060133). Especially preferred as marker
genes in this
contest are the dao1 gene (EC: 1.4. 3.3 : GenBank Acc.-No.: U60066) from the
yeast
Rhodotorula gracilis (Rhodosporidium toruloides) and the E. coli gene dsdA (D-
serine
dehydratase (D-serine deaminase) [EC: 4.3. 1.18;GenBank Acc.-No.: J01603).
Alternative marker genes are positive selection markers, which confer a growth
advantage to a
transformed plant in comparison with a non-transformed one. Such selection
markers are
described e.g., in EP-A 0 601 092. Positive selection markers may include (but
shall not be
limited to) mannose-6-phosphate isomerase (in combination with mannose),
UDPgalactose-4-
epimerase (in combination with e.g., galactose), wherein mannose-6-phosphate
isomerase in
combination with mannose is especially preferred.
Marker genes conferring a growth advantage might be used in combination with
marker genes
providing resistance against a herbicide, D-amino acid or antibiotic.
Particularly preferred marker genes are as follows:
A particularly preferred selectable marker gene is the acetohydroxy acid
synthase (AHAS)
gene, in particular a mutated AHAS gene. The acetohydroxy acid synthase enzyme
(also known
as acetolactate synthase, or ALS) is a protein found in plants and
microorganisms and which
catalyzes the first step in the synthesis of the branched-chain amino acids
(valine, leucine, and
isoleucine). Preferably, it has enzymatic activity as set forth in the Enzyme
Commission Code
EC 2.2.1.6. The mutated AHAS protein, preferably, confers resistance to at
least one
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
12
imidazolinone herbicide. lmidazolinone herbicides are well known in the art,
and, preferably,
include imazapyr, imazaquin, imazethapyr, imazapic, imazamox and
imazamethabenz.
Preferably, the imidazolinone herbicide is imazaquin. More preferably, the
imidazolinone
herbicide is imazethapyr. Most preferably, the imidazolinone herbicide is
imazapyr.
Preferred mutated AHAS genes are disclosed in W02004/005516 or W02008/124495
which
herewith is incorporated by reference with respect to its entire disclosure
content. Further
preferred mutated AHAS genes are disclosed in W02006/015376 or W02007/054555
or
US20100287641. The mutated AHAS enzyme preferably confers resistance to
imidazolinone
herbicides.
The polynucleotide sequence of a particular preferred mutated AHAS gene is
shown in
GenBank-Accession Number FW503642.1 GI:313050309. The resulting mutated AHAS
polypeptide comprises, inter alia, a 5653N mutation.
Further preferred selection marker genes are marker genes that confer
resistance or increased
tolerance to the toxic effects imposed by D-amino acids. Such preferred marker
genes,
preferably, encode for proteins which are capable of metabolizing D-amino
acids. Preferred D-
amino acids are D-alanine and D-serine. Particularly preferred marker genes
encode for D-
serine ammonialyases, D-amino acid oxidases and D-alanine transaminases.
Preferred
examples for such marker genes encoding for proteins which are capable of
metabolizing D-
amino acids are those which are as disclosed in W003/060133, W005/090584,
W007/107516
and W008/077570 which are herewith incorporated by reference with respect to
their entire
disclosure content.
Several methods are known for the transformation of plant cells.
Transformation of cells
comprised by the target tissue is, preferably, achieved by Agrobacterium-
mediated
transformation, by naked DNA transformation such as electroporation and PEG-
mediated
transformation, or by particle bombardment.
It is particularly preferred that step b) is carried out by co-cultivating the
explant with
Agrobacterium comprising a T-DNA. Said T-DNA shall comprise the polynucleotide
comprising
the at least one plant expression cassette for a selectable marker gene as
referred to in step b)
of the method of the present invention. Preferably, the co-cultivation of the
explant with
Agrobacterium shall allow for transforming cells comprised by the wounded
transformable
explant so that a chimeric explant is obtained. How to co-cultivate an explant
with
Agrobacterium is well known in the art and, e.g., described in U52009/0049567.
In the context
of the studies carried out in the context of the present invention, both solid
and liquid co-
cultivation media were successfully used for transformation. For co-
cultivation, the explants are,
preferably, inoculated with an Agrobacterium culture resuspended in liquid co-
cultivation
medium for a few minutes to a few hours, typically about 10 minutes to 3
hours, preferably
about 0.5 hours to 1 hour. The Agrobacterium are permitted to co-cultivate
with the target tissue
for several days, typically three to five days in the dark, preferably, in
liquid co-cultivation
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
13
medium or on plates with (solidified) co-cultivation medium. Preferred co-
cultivation media are
described in the Examples section. During the co-cultivation step, the
Agrobacterium transfers
its T-DNA into some cells of the target tissue. Preferably, the co-cultivation
is carried out under
in vitro conditions, i.e. under sterile conditions. Normally no selection
compound is present
during this step.
Preferably, if the explant comprises wounded meristematic tissue of the
primary or a higher leaf
node (see above), cells comprised by said wounded meristematic tissue are
transformed (see
e.g. also US2009/0049567). Thus, cells comprised by the wounded meristematic
tissue are the
target of the transformation. Accordingly, the co-cultivation, preferably,
shall allow for
transforming cells comprised by the wounded meristematic tissue of the primary
or a higher leaf
node. Thereby, chimeric explants are obtained, i.e. explants comprising cells
that are
transformed with the at least one plant expression cassette for a selectable
marker gene, and
cells that not transformed with the at least one plant expression cassette for
a selectable marker
gene.
Preferably, if the explant comprises wounded meristematic tissue of the
cotyledonary node,
cells comprised by said wounded meristematic tissue are transformed. Thus,
cells comprised by
the wounded meristematic tissue of the cotyledonary node are the target of the
transformation.
Accordingly, the co-cultivation, preferably, shall allow for transforming
cells comprised by the
wounded meristematic tissue of the cotyledonary node. Thereby, chimeric
explants are
obtained.
Preferably, if the explant comprises wounded epicotyl tissue, cells comprised
by said wounded
epicotyl tissue are transformed (see, e.g., Wright et al (Plant Cell, Tissue
and Organ Culture 8:
83 to 90 (1987)). Thus, cells comprised by the wounded epicotyl tissue are the
target of the
transformation. Thereby, chimeric explants are obtained.
The term "Agrobacterium" as used herein means all species of the Agrobacterium
family
(including Agrobacterium tumefaciens and Agrobacterium rhizogenes).The
principles of plant
transformation by means of Agrobacterium-mediated DNA transfer are well known
in the art
(Horsch R B et al. (1985) Science 225: 1229 pp).
Agrobacterium is a soil borne phytopathogen that integrates a piece of DNA (T-
DNA) into the
genome of a large number of dicotyledonous and few monocotyledonous plants
(Chilton, et al.,
1977 Cell 11: 263-271; Hoekema, et al., 1985 Nature 303: 179-180; Bevan, 1984
Nucleic Acids
Res. 12: 8711-8721; Sheng and Citovsky, 1996 The Plant Cell, Vol. 8.1699-
1710). Preferred
Agrobacterium strains are Agrobacterium tumefaciens which typically causes
crown gall in
infected plants, and Agrobacterium rhizogenes which typically causes hairy
root disease in
infected host plants. However, the Agrobacterium strains as used in the
context of the present
invention, preferably, shall lack the ability of causing crown gall disease
and hairy root disease,
respectively (which can be achieved by using disarmed Agrobacterium strains,
see below).
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
14
The use of Agrobacterium, particularly, of Agrobacterium tumefaciens (but also
of
Agrobacterium rhizogenes) for plant transformation is known as such (for a
review see Gelvin,
2003 Microbiol Mol Biol Rev. 67(1):16-37). For Agrobacterium-mediated plant
transformation,
the gene of interest is placed between the left and right border repeats of
Agrobacterium T-DNA
(transfer DNA). Afterwards, the T-DNA region containing the gene of interest
is stably integrated
into the plant genome by using an appropriate plant transformation protocol.
Various strains of Agrobacterium having different chromosomal backgrounds and
Ti-plasmid
content can be used for transformation. However, it is preferred that the
Agrobacterium strain
contains a disarmed Ti-plasmid or a disarmed Ri-plasmid. A disarmed Ti-plasmid
is understood
as a Ti-plasmid lacking its crown gall disease mediating properties but
otherwise providing the
functions for plant infection. A disarmed Ri-plasmid is understood as a Ri-
plasmid lacking its
hairy-root disease mediating properties but otherwise providing the functions
for plant infection.
Agrobacterium strains to be used for transforming plants cells are selected
from LBA4404,
GV2260, GV3600, EHA101, EHA105, AGL-1, LBA9402, GV3101, C0R341, C0R356,
UIA143,
pCH32, BIBAC2, C58C1, pMP90 and AGT121. In a preferred embodiment the
Agrobacterium
strain is selected from the group consisting of C58C1, EHA101, pMP90, SHA017,
and
LBA4404. In another preferred embodiment the Agrobacterium strain is a
disarmed variant of
K599 (NCPPB 2659) which, preferably, carries a disarmed variant of pRi2659 as
disclosed in
W003/017752.
Preferably, the Agrobacterium to be used in the context of the method of the
present invention,
include a DNA construct (e.g., a binary vector) comprising a T-DNA which
comprises an
expression cassette for a selectable marker gene. Preferably, said T-DNA
comprises at least
one expression cassette for an agronomically valuable trait. As a result of
the Agrobacterium-
mediated transfer, said T-DNA will normally be present, i.e. stably
integrated, in the genome of
the transformed cells.
In order to allow for transformation, the Agrobacteria are prepared by known
methods. The T-
DNA comprising Agrobacterium strain may, for example, be grown in liquid YEP
medium
supplemented with the appropriate antibiotic. For co-cultivation, the bacteria
are preferably
resuspended in liquid co-cultivation medium. The concentration of
Agrobacterium used for co-
cultivation may be varied. Thus, generally a range of Agrobacterium
concentrations from 0D600
0.1 to 3.0 and a range of co-cultivation periods from a few hours to 7 days
can be used. It is
particularly preferred that the Agrobacterium concentration ranges from 0D600
1.0 to 2Ø
Another, also preferred method for the transformation of cells is particle
bombardment The term
"particle bombardment" as used herein, preferably, refers to the process of
accelerating
particles coated with the gene of interest towards a target biological sample
(particularly cells,
and plant tissue) in order to effectively wound the cell membrane of a cell in
the target biological
sample and/or entry of the particles into the target biological sample.
Methods for particle
bombardment (frequently also referred to as "biolistic bombardment") are known
in the art, se,
e.g., US 5,584,807), and are commercially available (e.g., the helium gas-
driven microprojectile
accelerator (PDS-1000/He) (BioRad).
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
In a preferred embodiment, the method further comprises the step b1) of
transferring the
explant of step a) (in particular, a co-cultivated explant) to a shoot
induction medium and
cultivating said explant on said shoot induction medium. Preferably, the
explant is transferred to
said medium, preferably, by laying the explant on the shoot induction medium,
preferably, in a
5 horizontal position. It is also envisaged that the explant is submerged
in said medium
(preferably, also in horizontal position). By carrying out step b1), an
explant is generated
comprising shoot tissue comprising cells comprising the at least one plant
expression cassette
for a selectable marker gene. Said shoot tissue is herein also referred to as
"de novo formed
shoot tissue". Preferably, said shoot tissue is derived from the tissue which
is the target of
10 transformation.
Preferably, the shoot induction medium comprises at least one plant growth
factor allowing for
the induction of shoots, in particular a cytokinin. Preferably, said at least
one plant growth factor
is comprised by the said shoot induction medium in a concentration suitable to
induce de novo
15 shoot induction from the target tissue. Preferably, the shoot induction
medium comprises a
selection compound for the selectable marker gene comprised by the at least
one plant
expression cassette.
The term "plant growth factor" as used herein, preferably, encompasses
naturally occurring or
synthetic (not naturally occurring) compounds that can regulate plant growth
and development.
Preferred plants growth factors are cytokinins or auxin.
A preferred auxin is selected from the group consisting of indoleacetic acid
(IAA), indole-3-
butyric acid (IBA), naphthylacetic acid (NAA), and 2,4-dichlorphenoxyacetic
acid (2,4-D). A
particularly preferred auxin is IAA (see Examples for preferred
concentrations).
Preferred cytokinins are kinetin, zeatin, 6-isopentenyladenine (IPA) and 6-
benzyladenine/6-
benzylaminopurine (BAP).
The shoot induction medium, preferably, comprises cytokinins, in particular
kinetin and/or BAP.
The shoot induction medium may further contain an antibiotic in order to stop
or retard growth of
the remaining Agrobacterium cells. Preferably, said antibiotic is not the
selection compound for
the selectable marker gene that shall be transformed into the plant. Preferred
antibiotics are
carbenicillin or Timentin which is a mixture of ticarcillin disodium and
clavulanate potassium.
Preferably, the antibiotic is contained by the medium in an amount suitable to
stop or retard
growth of Agrobacterium cells. Alternatively, the explants may be washed with
a solution
contain said antibiotic after co-cultivation.
The shoot induction medium, preferably, further comprises a selection compound
(for the
selectable marker gene used for transformation) in an amount that is
sufficient to allow for the
selection of transgenic cells. An explanation of the term "in an amount that
is sufficient to allow
for the selection of transgenic cells" is given herein below in the context of
step c) of the method
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
16
of the present invention. Preferred amounts of the selection compounds as
given in the context
of step c) also apply to the shoot induction medium.
The explants are, preferably, incubated on said shoot induction medium until
shoots have been
developed. Formation of transgenic shoot primordia becomes visible around 1
week on shoot
induction medium and, on average, explants are cultured in a shoot induction
medium for about
3 to 6 weeks to allow most explants to form new shoots. Therefore, the
explants may be
cultivated for up to 5 weeks on shoot induction medium. However, the
cultivation of the explant
on shoot induction medium may be significantly shorter than 5 weeks since it
has been
surprisingly shown in the studies carried out in the context of the present
invention, that the
cultivation time on shoot induction medium can be reduced when carrying out
the method of the
present invention. This surprising effect results in an overall reduction of
time needed for
obtaining fully regenerated plants. Accordingly, in step b1) of the method of
the present
invention, the explants are preferably, cultivated on shoot induction medium
for 1 to 4 weeks,
more preferably, for 1 to 3 weeks, even more preferably, for 2 to 3 weeks
before transferring the
explants to a growing medium as described herein below.
In step c) of the method of the present invention the explant shall be
transferred to a growing
medium. The growing medium shall allow for promoting elongation of transgenic
shoots if step
b1) has been carried out. The growing medium shall allow for de novo formation
of transgenic
shoots and for elongation of transgenic shoots if step b1) has not been
carried out. The growing
medium can be any medium which allows for the elongation of transgenic shoots
and for the
growth of a plant (see below). In the context of the method of the present
invention, the growing
medium, preferably, comprises at least one selection compound for said
selectable marker
gene. Preferably, said at least one selection compound is comprised by the
growing medium in
an amount that is sufficient to allow for the selection of transgenic cells,
i.e. of cells that
comprise the polynucleotide comprising the plant expression cassette as
referred to above.
Preferably, the explant obtained by carrying out step b1) i.e. the explant
which was incubated
on shoot induction medium and which comprises de novo formed shoot tissue is
transferred to
the growing medium. However, it is also envisaged that step c) of the method
of the present
invention is carried out immediately after step b) (and, thus, without
carrying out step b1).
Particularly, it is envisaged to transfer the explant that has been co-
cultivated (in step b)) with
Agrobacterium comprising a T-DNA as described above directly to the growing
medium. In this
case the growing medium shall allow for the formation and elongation of
transgenic shoots. If
step b1) has been carried out (and, thus, if the explant has been cultivated
on shoot induction
medium), the de novo formed shoot comprised by the explant, preferably, shall
be allowed to
elongate after transferring the explant to the growing medium. How to achieve
the formation of
and elongation of transgenic shoots is well known in the art.
Preferably, the explant is placed vertically (and, thus, in an upward
position) in the growing
medium with the target tissue up. More preferably, the explant is placed
vertically in the growing
medium with the target tissue up so that the target tissue comprised by the
explant is not in
direct contact with the surface of the growing medium. This is, preferably,
achieved by inserting
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
17
the hypocotyl or a portion thereof comprised by the explant into the growing
medium.
Preferably, the at least one cotyledon is not inserted into the growing
medium. Thus, it shall,
preferably, remain above the surface of the growing medium.
After inserting said hypocotyl or the portion thereof into said growing
medium, said explant is,
preferably, in an upward position (so that the target tissue comprised by the
explant is not in
direct contact with the surface of the growing medium). This also applies if
the further step bl)
has been carried out. In this case, the de novo formed shoot tissue comprised
by the explant
shall not be in direct contact with the surface of the growing medium after
the transfer of the
explant to said growing medium.
Of course, not the entire hypocotyl has to be inserted into the growing
medium. It is sufficient to
insert a portion of the hypocotyl into said growing medium which is sufficient
to keep the explant
in an upward position. Which portion allows for keeping the explant in an
upward position can
be determined by the person skilled in the art without further ado.
If the explant does not comprise a cotyledon (which may be the case if the
cotyledon falls off
when trying to insert it in the hole) a portion of the epicotyl is,
preferably, inserted into the
growing medium. In this case, the explant shall be also placed vertically in
the growing medium
so that the target tissue is not in direct contact with the surface of the
growing medium.
However, it is particularly envisaged that the epicotyl remains above the
surface of the growing
medium after transfer to the growing medium.
The growing medium can be any medium which allows for the growth of plants.
Preferably, the
growing medium is a solid medium.
Preferably, the growing medium (herein also referred to as "growth medium") is
selected from
the group consisting soil, humus, and a hydroponic medium. The most preferred
growing media
are hydroponic media. Preferably, the explant is cultivated under ex vitro
conditions, and, thus,
under non-sterile conditions, after transferring said explant to said growing
medium.
Moreover, it is also envisaged that the growing medium is a plant tissue
culture medium. In this
case, step c) is carried out under in vitro conditions, i.e. under sterile
conditions. Preferably, the
plant tissue culture medium is selected from the group consisting of Gamborg
B5 medium,
Murashige & Skoog medium, Linsmaier & Skoog medium, and Murashige & Miller
medium. Of
these, the Gamborg B5 and the Murashige & Skoog media are particularly
preferred.
The use of hydroponics for the growth of plants is known as such (for a review
see
Hydroponics: A Practical Guide for the Soilless Grower, J. Benton Jones,
published CRC Press,
2004). Hydroponics is a technology of growing plants in nutrient solutions
without soil. The two
main types of hydroponics are liquid hydroponic mediums and substrate
hydroponic mediums.
In the context of the method of the present invention the hydroponic medium is
a substrate
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
18
hydroponic medium and, thus, a soil-less cultivation medium that comprises a
hydroponic
compound and a nutrient medium.
Preferably, the hydroponic compound comprised by the hydroponic medium is
inorganic. More
preferably, the hydroponic compound is a mineral wool. Most preferably, the
hydroponic
compound is acidic phenol-formaldehyde-, urea formaldehyde- or cellulose-based
foams. Such
foams, preferably, have an open cell structure mimicking the plant cellular
structure. Preferred
foams are available as Oasis root medium from Smithers-Oasis Co. also called
Oasis
wedges, (Kent, OH, USA) or are available as cellular foam rooting sponges from
Grow-Tech
(Lisbon Falls, ME, USA). E.g., preferred acidic phenol formaldehyde based
foams (also know as
phenolic foams) are described in US 2,753,277.
Mineral wool hydroponic compounds for plant growth are known in the art and,
preferably,
comprised of coherent matrix of mineral fibers made from natural or synthetic
minerals or metal
oxides. Preferably, the mineral wool is selected from the group consisting of
glass wool, rock
wool and slag wool. Also contemplated are mixtures of the aforementioned
mineral wools. The
most preferred mineral wool in the context of the present invention is rock
wool (see also
W001/87070). Rock wool, frequently also referred to as stone wool, is a
mineral wool
manufactured from volcanic rock. It is comprised of pores (about 95%) and
solids in the form of
rock fibres (5%). Preferably, the rock wool is manufactured from basalt and
limestone. For
manufacturing rock-wool, these raw materials are, e.g., heated in an oven at
about 1500 C,
when they melt into lava. The lava may then poured onto a number of discs
spinning at a high
speed. The centrifugal force throws drops of lava from the discs, which are
then transformed
into threads. The threads are compressed to form a solid mass, which then may
be sawn into
slabs and blocks.
It is to be understood that the hydroponic medium can be provided in many
shapes and sizes,
e.g., mini cubes, cubes, blocks, mats and slabs (see also Examples).
Of course, the growing medium shall also comprise nutrients. The medium,
preferably,
comprises essential elements needed by the plant for growth and development
such as
nitrogen, phosphorous, and potassium. Preferably, the growing medium also
comprises a plant
growth regulator, in particular an auxin such as IAA.
In the context of the method of the present invention, the growing medium as
referred to above
shall comprise at least one selection compound for the selectable marker gene
comprised by
the expression cassette described above. The selection compound, preferably,
is already
present in the growing medium when explant is transferred to the growing
medium. However, it
is also contemplated that the selection compound is added to the growing
medium after the
transfer. If the selection compound is added after the transfer, the compound
is, preferably,
added immediately, one day, two days, three days or four days after the
transfer. Preferably, the
selection compound is added by watering the explants with a solution
containing the selection
compound, in particular once or twice a week.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
19
Preferably, the growing medium also comprises a plant growth factor, in
particular IAA. The
plant growth factor, preferably, is already present in the growing medium when
explant is
transferred to the growing medium. However, it is also contemplated that the
selection
compound is added to the growing medium after the transfer (see above). The
plant growth
factor, preferably, allows for root induction.
As set forth above, the selection compound shall be comprised by the growing
medium in an
amount that is sufficient to allow for the selection of transgenic cells. The
amount of the
selection compound in the medium that is sufficient may depend on the plant to
be transformed
as well as on the selection compound itself. Sufficient amounts of the
selection compound,
however, can be determined by the person skilled in the art without further
ado. E.g. sufficient
amounts can be determined by comparison experiments in which various amounts
of the
selection compounds are tested. Usually, an amount of the selection compound
may be
regarded as sufficient, if the growth of cells which have not been transformed
with a plant
expression cassette for the corresponding selectable marker is inhibited,
whereas cells which
have been successfully transformed with said plant expression cassette are
capable of growing
(and, thus, cell division takes place). Preferred amounts of specific
selection compounds that
are considered to be sufficient to allow for the selection of transgenic cells
are given herein
below.
If the selectable marker gene encodes for AHAS or a mutated AHAS, the growing
medium
comprises preferably, at least one lmidazolinone herbicide (i.e the
corresponding selection
compound), in particular lmazapyr, in an amount of, preferably, 0.5 pM to 25
pM, more
preferably, of 1 pM to 10pM, and, even more preferably of 1 pM to 5 pM, most
preferably of 1
pM to 3 pM. It is also preferred to water the explants with a solution
containing the
aforementioned amounts of the selection compound. Further preferred amounts of
lmazapyr are
given in the Examples.
If the selectable marker gene confers resistance or increased tolerance
against the toxic effects
imposed by D-amino acids (in particular if the marker gene encodes for a D-
serine
ammonialyase) the growing medium, preferably, comprises at least one D-amino
acid, in
particular D-serine, in an amount of 0.05 mM to 100 mM, preferably 0.1 mM to
50 mM, and
more preferably 5 mM to 7.5 mM. It is also preferred to water the explants
with a solution
containing the aforementioned amounts of the selection compound.
Preferred concentrations of other selective compounds are for example:
With the phosphinothricin resistance gene (bar) as the selective marker,
phosphinothricin may
be included in the medium at a concentration of from about 1 to 75 mg/I.
Typical concentrations
for selection are from about 1 to about 15 mg/I. The preferred concentrations
for selection are
about 3 to 5 mg/I.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
With the kanamycin resistance gene (neomycin phosphotransferase, NPTI I) as
the selective
marker, kanamycin at a concentration of from about 3 to 200 mg/I may be
included in the
medium. Typical concentrations for selection are 5 to 50 mg/I.
5 It is known that plants generally may be selected by contacting the
selection compound by
spraying the plants/explants with a solution containing the selecting agent or
by adding the
selection compound onto the leaves of the plant/explant. However, in the
context of the present
invention, the selection compound shall be present in the growing medium.
Thus, it is taken up
by the non-transgenic parts of the explant and is translocated to epicotyls
and above, rather
10 than being contacted with the plant/explant by spraying the
plants/explants with a solution
containing the selecting agent or by adding the selection compound onto the
leaves of the
plant/explant.
In a further step d) of the method of the present invention said explant shall
be allowed to form a
15 shoot and the shoot shall be allowed to elongate. If step bl) has been
carried out, the formed
shoot (or formed shoot primordium) shall be allowed to elongate. The
formed/elongated shoot,
preferably, comprises plant cells comprising said least one plant expression
cassette for said
selectable marker gene.
20 Step d) may be carried out under in vitro or ex vitro conditions.
Preferably, step d) is carried out
under in vitro conditions, if the growing medium is a plant tissue culture
medium. If the growing
medium is a hydroponic medium, soil or humus, step d) is preferably, carried
out under ex vitro
conditions and, thus, under non-sterile conditions.
The elongation of shoots on hydroponic medium is advantageous since it takes
only 2 weeks to
get elongated shoots as compared to 6-8 weeks in a plant tissue culture
medium. Thereby, the
time needed for producing transgenic plants can be significantly reduced.
The method of the present invention, preferably, comprises the further step e)
of regenerating a
transgenic plant from said shoot formed and/or elongated in step d), and thus,
from the plantlet
derived from step d). The regenerated plants, preferably, comprise inserted
into their genome
the polynucleotide comprising said at least one plant expression cassette for
said selectable
marker gene.
In a preferred embodiment, step e) comprises the steps of
el) separating the elongated shoot obtained in step d) from the explant,
e2) transferring the separated elongated shoot to a growing medium, and
e3) regenerating a transgenic plant from said elongated shoot.
In step el) only elongated shoots are, preferably, separated. Whether a shoot
can be
considered as elongated can be determined by the skilled person without
further ado.
Preferably, the elongated shoots that are separated are shoots with full
trifoliate leaf formation.
If a soybean explant has been transformed, shoots with elongated stems having
a length of,
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
21
preferably, at least 2 cm, or more preferably, of at least 3 cm, or, even more
preferably, of at
least 5 cm are separated.
The separation of the elongated shoot from the explant can be carried out by
any method
deemed appropriate. Preferably, the separation is done by cutting the
elongated shoot from the
explant using a pair of scissors.
The separated elongated shoots shall be transferred to a growing medium. The
term "growing
medium" has been described above. Preferably, the growing medium is a
hydroponic medium.
The growing medium used for the regeneration of the plant may or may not
comprise the
selection compound for the selectable marker gene. Preferably, it comprises
the selection
compound. The separated shoot(s) is/are transferred to the growing medium to
induce root
formation. Root formation, preferably, takes 1 to 2 weeks. The plants may be
grown to maturity
on the growing medium. However, it is preferred to transfer the plantlets
having developed roots
to soil and to grow them to full maturity on soil (e.g. if they have been
transferred to a
hydroponic medium in step e2). After the transfer to soil, the rooted shoots
may be kept in the
growth chamber for 1 to 3 weeks before they are transferred to the greenhouse.
In a further step e4), the regenerated plants are allowed to develop seeds.
Preferably, the
seeds are collected in a further step e5). Preferably, the cells comprised by
the seeds comprise
the polynucleotide comprising the at least one plant expression cassette for a
selectable marker
gene (see, e.g. step a) of the method of the present invention, and are, thus,
transformed with
said plant expression cassette. Preferably, the cells are stably transformed
with said plant
expression cassette. The term "stably transformed" as used herein, preferably,
means that the
polynucleotide comprising the at least one plant expression cassette for a
selectable marker
gene is integrated into genome of the cells.
In an even further preferred embodiment of the method of the present
invention, the plant in
step e) is regenerated without separating the elongated shoot from said
explant. The plants may
be grown to maturity on the growing medium. However, it is preferred to
transfer the plantlets
having developed roots to soil and to grow them to full maturity on soil.
Preferably, the plant is
allowed to develop flowers. More preferably, the plant is allowed to develop
seeds. In a further
step, the developed seeds may be collected. Preferably, the cells comprised by
the seeds
comprise the polynucleotide comprising the at least one plant expression
cassette for a
selectable marker gene (see, e.g. step a) of the method of the present
invention, and are, thus,
transformed with said plant expression cassette. Preferably, the cells are
stably transformed
with said plant expression cassette.
By carrying out step e) without separating the elongated shoot from the
explant, a plant is
regenerated comprising non-transgenic epicotyl and/or hypocotyl tissue, i. e.
tissue that is not
transformed with the polynucleotide comprising the at least one plant
expression cassette for a
selectable marker, and transgenic tissues/organs such as the stem, leaves,
flowers and/or
seeds which are derived from the transformed cells of the target tissue of the
transformation.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
22
Said transgenic tissue/organs comprise the polynucleotide comprising at least
one plant
expression cassette for a selectable marker.
Accordingly, the present invention relates to a plant obtained or obtainable
by the method of the
present invention. In one embodiment, said plant obtained or obtainable by the
method of the
present invention is a composite plant. A composite plant, is a plant which
comprises non-
transgenic parts, in particular epicotyl and/or hypocotyl tissue and
transgenic parts which are
derived from the transformed plant cell. Said plant may be created by inducing
transgenic
shoots on a wildtype epicotyl and/or hypocotyl tissue under selective
conditions and then
transferring the wildtype epicotyl and/or hypocotyl tissue comprising
transgenic shoots to a
rooting step under non-selective conditions. "Non transgenic" in the context
of the plant
obtained or obtainable by the method of the present invention means that the
tissues or parts of
the plant referred to above do not comprise, and, thus, have not been
transformed with the
polynucleotide comprising at least one expression cassette for a selectable
marker.
Preferably, said plant has developed flowers. More preferably, said plant has
developed seeds.
Most preferably, the seeds developed by the plant comprise the transformed
polynucleotide
comprising at least one plant expression cassette for a selectable marker.
Thus, the
transformed polynucleotide will be transmitted to the following generation.
Fig. 3 shows a
composite plant.
The present invention is advantageous for the following reasons:
Usually, transgenic plants are obtained by transforming a plant tissue
susceptible to
Agrobacterium-mediated transformation with a suitable Agrobacterium strain.
After co-
cultivation, the explant is incubated on shoot induction medium and transgenic
shoots are
selected by using a selectable marker gene. After shoot elongation, shoots are
separated from
the explants and root growth is induced on a root induction medium. Usually
all these steps are
carried out under in vitro conditions, i.e. under sterile conditions. Thus,
many steps are carried
out under sterile conditions. This increases the risk of fungal or bacterial
contamination.
Moreover, the aforementioned protocol is very time-consuming. E.g., when
transforming
soybean as described above, the transformation takes as many as 100 days or
even more.
However, when applying the method of the present invention, the timeline for
soybean
transformation can be shortened and rooted transgenic soybean plants may be
obtained within
50-60 days. In particular, the timeline can be shortened when incubating the
explant only for a
short time on shoot induction medium, and/or when the plants are grown to
maturity without
separating the elongated shoots from the explants. This has been shown for
various soybean
varieties such as 93061, Williams82, Stoddard and Jake as well as for A.
tumefaciens and A.
rhizogenes.
In accordance with the method of the present invention, the explants are
placed vertically on the
growing medium, e.g soil, humus, or a hydroponic medium, with their residual
hypocotyl part
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
23
inserted into the growing medium, e.g. a hydroponic medium, like Oasis TM
wedges.
Nevertheless, the selection has been shown to be effective although the
transformed plant cells
comprised by the explant are not in direct contact with the surface of the
growing medium
comprising the selection compound. Only the non-transformed
hypocotyl/cotyledonary tissue is
in direct contact with the growing medium and, thus, with the selection
compound. Thus, the
results of the studies carried out in accordance with the present invention
are surprising.
Moreover, the use of hydroponic media is is advantageous since it
significantly reduces the time
needed for shoot elongation as compared to other systems, e.g. in a plant
tissue culture
medium. Thereby, the overall time needed for producing transgenic plants can
be significantly
reduced.
Moreover, when applying the method of the present invention, the number of
steps carried out
under in vitro condition can be reduced resulting in a reduced risk of
contamination.
Moreover, when carrying out step e) without separating the elongated shoot
from the explant
the number of steps required for obtaining a transgenic plant and/or
transgenic seeds can be
reduced.
The definitions and explanation given herein above in the context of the first
method of the
present invention, apply mutatis mutandis to the method of the present
invention described
herein below (except if stated otherwise).
Moreover, the present invention relates to a method for producing a transgenic
plant,
comprising the steps of
(i) providing a wounded transformable explant, comprising at least one
cotyledon,
and wounded meristematic tissue of a primary or higher leaf node (in
particular
wounded axillary meristematic tissue of a primary or higher leaf node),
(ii) transforming cells comprised by the said explant with a polynucleotide
comprising
at least one plant expression cassette for a selectable marker gene,
(iii) transferring said explant to a shoot induction medium and cultivating
said explant
on said shoot induction medium comprising at least one selection compound for
said selectable marker gene, thereby allowing formation of at least one de
novo
formed shoot comprising plant cells comprising said least one plant expression
cassette for said selectable marker gene,
(iv) separating the meristem region of said primary or higher leaf node
comprising
said at least one de novo formed shoot and transferring said meristem region a
hydroponic medium, said hydroponic medium comprising at least one selection
compound for said selectable marker gene, and allowing said at least one de
novo formed shoot to elongate, and
(v) regenerating a transgenic plant from said so derived plantlet.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
24
Preferably, steps (i) and (ii) of the aforementioned method correspond to
steps (a) and (b) of the
first method described in this specification. Moreover, the wounded
transformable explant may
further comprise a hypocotyl or a portion thereof as described elsewhere
herein. However, it is
also preferred that the wounded transformable explant does not comprise
hypocotyl tissue.
Preferably, the explant is obtained by removing the roots and the hypocotyl or
part thereof from
the seedling. Also one cotyledon may be removed. Of course, the wounded
transformable
explant comprises the epicotyl.
Preferably, steps (i) and (ii) are carried out under in vitro conditions.
Preferably, step (iii) of the aforementioned method corresponds to step (b1)
of the first method
described in this specification. By carrying out step (iii), the explants, in
particular, the co-
cultivated explants, are preferably allowed to form shoots comprising plant
cells comprising said
least one plant expression cassette for said selectable marker gene (de novo
shoot formation).
Preferably, the shoot induction medium comprises at least one plant growth
factor allowing for
the induction of shoots. Preferred plant growth factors allowing for the
induction of shoots, i.e.
for de novo formation of shoots are described elsewhere herein. Preferably,
step (iii) is also
carried out under in vitro conditions.
The explant is, preferably, incubated on said shoot induction medium until de
novo formed
shoots have been developed. Therefore, the explant may be cultivated for up to
5 weeks on
shoot induction medium. In accordance with the aforementioned method, the
explant is,
preferably, cultivated on shoot induction medium for 3 to 5 weeks, more
preferably, for 3 to 4
weeks, even more preferably, for 3 weeks before transferring the explants to a
growing medium
as described herein below. It is also contemplated that the explants are
cultivated on shoot
induction medium.
After cultivation on shoot induction medium, the meristem region of the
primary or higher leaf
node comprises a cluster of newly formed leaf or shoot structures. Thus, the
shoots from a
cluster of shoots (a shoot aggregate). Preferably, at least one of the de novo
formed shoots (in
particular one) comprises plant cells comprising said least one plant
expression cassette for
said selectable marker gene.
Some of the shoots comprised by the cluster may be non-transgenic. It is,
however, preferred
that at least one de novo formed shoot comprises plant cells comprising said
least one plant
expression cassette for said selectable marker gene.
In step iv) the meristem region (and, thus, the meristem) of primary or higher
leaf node
comprising the at least one de novo formed shoot (comprising plant cells
comprising said least
one plant expression cassette for said selectable marker gene) is isolated,
and, thus separated
from the explants. Preferably, the meristem region is separated from the
explant, by separating
it from the epicotyl. The separation from the explant can be carried out by
any method deemed
appropriate. Preferably, the separation is done by cutting the meristem region
from the explant
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
using a pair of scissors. The separated meristem region, preferably, comprises
a portion of the
epicotyl.
The separated meristem region is then transferred to a hydroponic medium,
preferably by
5 inserting a portion of it into the hydroponic medium. (for preferred
hydroponic media, see
elsewhere herein, in particular step c) of the first method described in this
specification). If the
separated meristem region comprises a portion of the epicotyl, said portion of
the epicotyl is
preferably inserted into the hydroponic medium. Preferably, said meristem
region is inserted
into the hydroponic medium in an upward position.
Said hydroponic medium, preferably, comprises at least one selection compound
for said
selectable marker gene (for details, see also step c) of the first method).
Moreover, after the
transfer, the at least one shoot comprising plant cells comprising said least
one plant expression
cassette for said selectable marker gene shall be allowed to elongate.
Moreover, the at least
one shoot shall be allowed to form roots. This may be achieved by adding
suitable plant growth
factors. Thereby, plantlets are obtained which are transformed with the
polynucleotide
comprising the at least one plant expression cassette for a selectable marker
gene.
In contrast to steps (i) to (iii), step (iv) shall be, preferably, carried out
under non-sterile, and
thus, under ex vitro conditions.
In a further step (v), plants are regenerated from the plantlets derived from
step (iv). The
regenerated plants, preferably, comprise inserted into their genome the
polynucleotide
comprising said at least one plant expression cassette for said selectable
marker gene.
Preferably, the regenerated plants are allowed to develop seeds. Preferably,
said seeds are
collected. Preferably, the cells comprised by the seeds comprise the
polynucleotide comprising
the at least one plant expression cassette for a selectable marker gene (see,
e.g. step a) of the
method of the present invention, and are, thus, transformed with said plant
expression cassette.
Preferably, the cells are stably transformed with said plant expression
cassette. The term
"stably transformed" as used herein, preferably, means that the polynucleotide
comprising the at
least one plant expression cassette for a selectable marker gene is integrated
into genome of
the cells.
Advantageously, it has been shown in the context of studies carried out for
the present
invention that the promotion of shoot elongation and root formation on a
hydroponic medium,
preferably, ex vitro has greatly reduced the timeline in generating transgenic
plants as
compared to the promotion of shoot elongation and/or root formation on other
systems. For
example, the time needed for shoot elongation could be reduced from 6 to 10
weeks to
approximately 28 days.
All references cited in this specification are herewith incorporated by
reference with respect to
their entire disclosure content and the disclosure content specifically
mentioned in this
specification.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
26
In the following, preferred embodiments of the present invention are
disclosed. The definitions
and explanations given herein above apply mutatis mutandis.
Embodiments
1. A method for producing a transgenic plant, comprising the steps of
a) providing a wounded transformable explant, comprising a hypocotyl or a
portion thereof,
at least one cotyledon, and wounded tissue selected from
i. wounded meristematic tissue of a primary or higher leaf node,
ii. wounded meristematic tissue of the cotyledonary node, and
iii. wounded epicotyl tissue
b) transforming cells comprised by the said explant with a polynucleotide
comprising at
least one plant expression cassette for a selectable marker gene,
c) transferring said explant to a growing medium by inserting the hypocotyl,
or portion
thereof, of said explant into said growing medium comprising at least one
selection
compound for said selectable marker gene,
d) allowing said explant to form a shoot and/or allowing the shoot to
elongate, said shoot
comprising plant cells comprising said polynucleotide comprising said least
one plant
expression cassette for said selectable marker gene, and
e) regenerating a transgenic plant from said shoot.
2. The method of embodiment 1, wherein step b) is carried out by co-
cultivating said explant
with Agrobacterium comprising a T-DNA, said T-DNA comprising the
polynucleotide
comprising at least one plant expression cassette for a selectable marker
gene.
3. The method of embodiments 1, wherein the explant in step a) is derived from
a 6 to 10 day
old seedling.
4. The method of embodiments 2 and 3, wherein the co-cultivation allows for
transforming cells
comprised by the wounded meristematic tissue so that a chimeric explant is
obtained.
5. The method of any one of embodiments 1 to 4, wherein the method comprises a
further step
b1) of transferring said explant to a shoot induction medium and cultivating
said explant on
said shoot induction medium.
6. The method of any one of embodiments 1 to 4, wherein step c) is carried out
immediately
after step b).
7. The method of any one of embodiments 1 to 6, wherein the explant is
cultivated under ex
vitro conditions after transferring said explant to a growing medium.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
27
8. The method of any one of embodiments 1 to 7, wherein step e) comprises the
steps of
el) separating the elongated shoot obtained in step d) from the explant,
e2) transferring the separated elongated shoot to a growing medium, and
e3) regenerating a transgenic plant from said elongated shoot.
9. The method of any one of embodiments 1 to 7, wherein the transgenic plant
in step e) is
regenerated without separating the elongated shoot from said explant.
10. The method of any one of embodiments 1 to 9, wherein the growing medium is
step c) is a
hydroponic medium.
11. The method of embodiment 10, wherein the hydroponic medium is a
formaldehyde or
cellulose based foam.
12. The method of any one of embodiments 1 to 11, wherein the selectable
marker gene is a
mutated AHAS gene (acetohydroxyacid synthase gene) or a marker gene that
confers
resistance or increased tolerance to against the toxic effects imposed by D-
amino acids, in
particular, a marker gene that encodes for a D-serine ammonialyase, a D-amino
acid
oxidase, or a D-alanine transaminase.
13. The method of embodiment 12, wherein the selectable marker gene is a
mutated AHAS
gene, and wherein the selection compound is an imidazolinone herbicide, in
particular
lmazapyr.
14. The method of any one of embodiments 1 to 13, wherein the plant is a
dicotyledonous plant.
15. The method of any one of embodiments 1 to 14, wherein the genus of the
plant is selected
from the group consisting of Glycine, Medicago and Phaseolus.
16. The method of embodiment 15, wherein the plant is Glycine max.
17. A plant obtainable by the method of embodiment 9.
18. The plant of embodiment 17, wherein the plant has developed flowers.
19. The plant of embodiments 17 and 18, wherein the plant has developed seeds.
The Figures show:
Fig. 1A: Preparation of explants: Explants are prepared by removing most of
the hypocotyl, one
cotyledon and all preformed leaves (including apical meristem) from 7 to 8-day
old soybean
seedlings.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
28
Fig. 1B: Wounded transformable soybean explant
Fig. 1C: Co-cultivation with Agrobacterium. Soybean explants were co-
cultivated with
Agrobacterium for approximately 5 days
Fig. 2A: Explants with formed leaf/shoot structures derived from a transformed
primary leaf
node. The explant has been inserted into the growing medium in an upward
position so that the
transformed cells are not in direct contact with the growing medium comprising
the selection
compound.
Fig. 2B: Separation of elongated shoots from the explants. After separation,
the shoots were
rooted individually.
Fig. 3A: Composite plant with a non-transgenic (wild-type) hypocotyl and
epicotyl transgenic
parts which are derived from the transformed plant cell. For obtaining this
plant, meristematic
tissue of a primary leaf node has been transformed. In contrast to the plants
shown in Fig. 2B,
the elongated shoots were not separated from the explant.
Fig. 3B: Transgenic shoot (containing DsRed gene) elongating from the primary
leaf node
region of a seedling explant on a hydroponic medium
The following examples are only intended to illustrate the present invention.
They shall not limit
the scope of the invention in any way.
Examples
Example 1. Sterilization and Germination of Soybean Seeds
Soybean seeds were sterilized in a desiccator with chlorine gas, which was
produced by adding
3.5 ml 12N HCI drop-wise into 100 ml bleach (5.25% sodium hypochlorite). After
24 to 48 hours,
seeds were removed from the desiccator and stored in room temperature for a
short period of
time before use. For seed germination, approximately 30 to 50 seeds were
plated on a solid
seed germination medium in a PlantCon container and grown under at 27 C for 7
to 8 days.
Example 2. Preparation of Agrobacterium Cultures and Explants for
Transformation
Agrobacterium cell cultures were prepared by streaking Agrobacterium (e.g., A.
tumefaciens or
A. rhizogenes) carrying the desired binary vector onto solid YEP growth medium
containing an
appropriate antibiotic, such as kanamycin or spectinomycin. They were grown in
an incubator
at 28 C. After approximately two days, one or several colonies are picked
(with a sterile
toothpick) and inoculated in 50 ml of liquid YEP medium with an appropriate
antibiotic
(kanamycin or streptomycin). They were then placed on a shaker and shaken at
200-250 rpm
(28 C) for about 24 hr or until an 0D660 between 1.0-1.5 was reached. Working
Agrobacterium
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
29
glycerol stocks were prepared by mixing an equal volume of Agrobacterium
suspension and
glycerol). Each 1 60-1 70 pl of Agrobacterium stocks were aliquot into a 200
pl Eppendorf tubes
and then stored at -80 C until use. The day before infecting explant with
Agrobacterium, 100-
150 pl of working Agrobacterium stock pl were pipette into 100-150 ml of YEP
in a 400 ml
centrifuge bottle. The centrifuge bottles were placed on a shaker and shaken
overnight at 28 C
or until an 0D660 between 1.0 and 1.5 was reached.
On the day when transformation experiments were carried out, the agrobacteria
were collected
by centrifuging them at 5,000 g for 8 minutes. The pellets were re-suspended
in a liquid co-
cultivation medium to the desired density (0D660 = 1.5) and placed at room
temperature for at
least 30 min before use.
The following table shows the composition of the liquid co-cultivation medium
(pH 5.4).
Ingredients Concentration/Units
Gamborgs B5 1/10 X
Salts
Sucrose 30 g/L
MES Hydrated 20 mM
Gamborg's 1X
Vitamins 1000X
Kinetin 5 uM
Giberellic Acid 0,5 mg/I
Acetosyringone 0,2 mM
Explants for Agrobacterium infection were prepared by removing most of the
hypocotyl, one
cotyledon and all preformed leaves (including apical meristem) from the 7 to 8-
day old seedling.
After co-cultivation with the re-suspended Agrobacterium mixture for 30
minutes, the explants
were transferred to petri plates and plated on a co-cultivation medium. They
were grown in the
dark at 25 C for 5 days. (The explants plants might be 1 to 3 inches in
length after the co-
cultivation period).
The following table shows the composition of the co-cultivation medium (pH
5.4) used for the
plates.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
Ingredients Concentration/Units
Gamborgs B5 Salts 1/10 X
Sucrose 30 g/L
MES Hydrated 20 mM
2-(N-
morpholino)ethanesulfonic
acid
Gamborg's Vitamins 1X
1000X
Kinetin 5 uM
Giberellic Acid 0,5 mg/I
Acetosyringone 0,2 mM
L-cysteine 4.4 mM
Sodium Thiosulfate 0.5 mM
DTT 0.5 mM
Example 3. Shoot Development
For shoot development, the Agrobacterium infected explants were transferred to
Oasis TM
5 wedges right after the co-cultivation period. Alternatively, the explants
were first grown in a
shoot induction media for 1-3 weeks before transfer to the wedges. The
explants were placed
vertically in the wedges with their residual hypocotyl part inserted into the
wedges. The wedges
were watered with a selection agent once or twice a week. (In the case where
explants were
infected with Agrobacterium harboring a construct that contains a mutated AHAS
gene, they
10 were watered with a solution that contains an imidazolinone herbicide as
a selective agent).
When shoots became elongated from the infected primary leaf node region, they
were
separated from the seedling and rooted individually in Oasis TM wedges. The
detached shoots
were watered with a solution containing an imidazolinone herbicide once or
twice a week.
When the shoots become rooted, they were transferred to soil and grown to
maturity in the
15 greenhouse. Alternatively, the whole explants (seedlings), with the
elongated shoots attached
to them, were transferred to soil and grown to maturity in the greenhouse.
Example 4.
20 Soybean cv. Williams82 seed germination, Agrobacterium preparation,
explant preparation, and
inoculation of Agrobacterium to explants were carried out as previously
described. A construct
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
31
that contains a mutated AHAS gene driven by a parsley ubiquitin promoter and a
[3 -
glucuronidase (GUS) gene driven by a parsley ubiquitin promoter, was delivered
to soybean
cells by Agrobacterium. After 5 days of co-cultivation, the Agrobacterium-
infected explants
were transferred to Oasis TM wedges with their hypocotyls inserted in the
wedges. They were
watered with a solution containing 1.5 uM lmazapyr once or twice a week. Leaf
tissues from
emerged shoots were collected and incubated in an x-gluc solution for
detection of expression
of GUS gene.
Experiment #Explants Infected #Explants with leaf
with Agrobacterium tissue showing
expression of gus
gene
A 50 2
B 50 2
C 70 1
Example 5.
Soybean cv. Williams82 seed germination, Agrobacterium and explant
preparation, and
inoculation of Agrobacterium to explants were carried out as previously
described. A construct
that contains a mutated AHAS gene driven by a parsley ubiquitin promoter and a
[3 -
glucuronidase (GUS) gene driven by a parsley ubiquitin promoter, was delivered
to soybean
cells by Agrobacterium. After 5 days of co-cultivation, the Agrobacterium-
infected explants
were transferred to a shoot induction medium (SIM) containing 3 pM lmazapyr.
After one week,
the seedling explant was transferred to Oasis TM wedges with their hypocotyls
inserted in the
wedges. They were watered with a solution containing 1-2 pM lmazapyr and 1
mg/I IAA once or
twice a week. Leaf tissues from emerged shoots were collected 2-4 weeks after
and incubated
in an x-gluc solution for detection of expression of GUS gene.
Experiment #Explants Infected #Explants with leaf
with Agrobacterium tissue showing
expression of gus gene
A 75 19
B 100 30
Example 6.
Soybean cv. Williams82 seed germination, Agrobacterium and explant
preparation, and
inoculations of Agrobacterium to explants were carried out as previously
described. A construct
that contains a mutated AHAS gene a gene coding for disease resistance was
delivered to
soybean cells by Agrobacterium. After 5 days of co-cultivation, 21 of the
Agrobacterium-infected
explants were transferred to Oasis TM wedges with their hypocotyls inserted in
the wedges.
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
32
They were watered with a solution that contains 1-2 pM lmazapyr once or twice
a week. 17 of
the explants with their elongated shoots were transferred to the greenhouse
and potted in soil.
Leaf tissues were collected and analyzed by Taqman TM assay for the presence
of AHAS gene.
Among those analyzed, 3 were positive.
Example 7.
Soybean cv. Williams82 seed germination, Agrobacterium and explant
preparation, and
inoculation of Agrobacterium to explants were carried out as previously
described. A construct
that contains a mutated AHAS gene driven by a parsley ubiquitin promoter, was
delivered to
soybean cells by Agrobacterium. After 5 days of co-cultivation, the
Agrobacterium-infected
explants were transferred to a shoot induction medium (SIM) containing 3 uM
lmazapyr. After
two weeks, the seedling explant was transferred to Oasis TM wedges with their
hypocotyls
inserted in the wedges. They were watered with a solution containing 1-2 uM
lmazapyr and 1
mg/I IAA once or twice a week. Leaf tissues were collected and analyzed by
Taqman TM assay
for the presence of AHAS gene. A total of 70 explants were infected with
Agrobacterium. 30
seedling explants were transferred to Oasis TM wedges. Among those analyzed, 5
were positive
for the presence of AHAS gene.
Example 8.
Soybean seed germination, Agrobacterium and explant preparation, and
inoculations were
carried out as previously described. A construct that contains a mutated AHAS
gene and a gene
coded for disease resistance was delivered to soybean cells by Agrobacterium.
After 5 days of
co-cultivation, the Agrobacterium-infected explants were placed in a shoot
induction medium
that contains lmazapyr as selection agent for 1-3 weeks. To promote shoot
elongation, the
seedling explant was transferred to Oasis TM wedges with their hypocotyls
inserted in the
wedges. Elongated shoots were separated from the explant and transferred to
Oasis TM wedges
for rooting. They were watered with a solution that contains 1-2 pM lmazapyr
and 1 mg/I IAA
once or twice a week. Rooted shoots were transferred to soil. Leaf tissues
were collected and
analyzed by Taqman TM assay for the presence of AHAS gene. Plants were grown
to maturity in
the greenhouse.
Experiment #Explants #Positive Transformation Genotype
events Efficiency (%)
A 69 4 6 Jake
B 99 25 25 Jake
C 48 4 8 Stoddard
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
33
Example 9.
Soybean seed germination, Agrobacterium and explant preparation, and
inoculations were
carried out as previously described. A construct that contains a mutated AHAS
gene driven by a
parsley ubiquitin promoter, was delivered to soybean cells by Agrobacterium.
After 5 days of
co-cultivation, the Agrobacterium-infected explants were placed in a shoot
induction medium
that contains lmazapyr as selection agent for 1-3 weeks. To promote shoot
elongation, the
seedling explant was transferred to Oasis TM wedges with their hypocotyls
inserted in the
wedges. Elongated shoots were separated from the explant and transferred to
Oasis TM wedges
for rooting. They were watered with a solution that contains 1-2 pM lmazapyr
and 1 mg/I IAA
once or twice a week. Rooted shoots were transferred to soil. Leaf tissues
were collected and
analyzed by Taqman TM assay for the presence of AHAS gene. Plants were grown
to maturity in
the greenhouse.
Experiment #Explants #Positive Transformation Genotype
events Efficiency (%)
A 51 6 12 Stoddard
B 54 6 11
Stoddard
C 84 5 6 Williams82
Example 10
Soybean cv. Williams82 seed germination, Agrobacterium and explant
preparation, and
inoculations were carried out as previously described. A construct that
contains a mutated
AHAS gene and a gene coded for disease resistance was delivered to soybean
cells by
Agrobacterium. After 5 days of co-cultivation, the Agrobacterium-infected
explants were placed
in a shoot induction medium that contains 3 pM lmazapyr. After 3-4 weeks, the
meristem region
of primary leaf node, with which a cluster of newly formed leaf or shoot
structures) were
separated from the epicotyls and transferred to Oasis wedges. They were
watered with a
solution that contains 1-2 pM lmazapyr and 1 mg/I IAA once or twice a week.
Rooted shoots
were transferred to soil. Leaf tissues were collected and analyzed by Taqman
TM assay for the
presence of AHAS gene. Plants were grown to maturity in the greenhouse.
Experiment #Explants #Positive events Transformation
Efficiency (%)
A 80 13 16.2
B 105 15 14.3
C 130 14 10.8
D 108 6 5.5
E 80 6 7.5
CA 02840550 2013-12-27
WO 2013/014585
PCT/1B2012/053705
34
Example 11.
Soybean cv. Williams82 seed germination, Agrobacterium and explant
preparation, and
inoculations were carried out as previously described. A construct that
contains a mutated
AHAS gene and a gene coded for disease resistance was delivered to soybean
cells by
Agrobacterium. After 5 days of co-cultivation, the Agrobacterium-infected
explants were placed
in a shoot induction medium that contains lmazapyr as selection agent for
approximately 2
weeks. To promote shoot elongation, the seedling explant was transferred to
Oasis TM wedges
with their hypocotyls inserted in the wedges. Elongated shoots were separated
from the explant
and transferred to Oasis TM wedges for rooting. They were watered with a
solution that contains
1-3 pM lmazapyr once or twice a week. Rooted shoots were transferred to soil.
Leaf tissues
were collected and analyzed by Taqman TM assay for the presence of AHAS gene.
Plants were
grown to maturity in the greenhouse.
Experiment #Explants #Positive events Transformation
Efficiency (%)
A 84 3 3.57
B 91 7 7.69
C 70 9 12.86
D 74 4 5.41
E 79 8 10.31
F 109 14 12.84
G 83 20 24.1
H 147 9 6.12
Example 12
Soybean cv. Willaims82 seed germination, Agrobacterium and explant
preparation, and
inoculations were carried out as previously described. A construct that
contains a mutated
AHAS gene and a second gene coded for herbicide tolerance was delivered to
soybean cells by
Agrobacterium. After 5 days of co-cultivation, the Agrobacterium-infected
explants were placed
in a shoot induction medium that contains lmazapyr as selection agent for
approximately 2
weeks. To promote shoot elongation, the seedling explant was transferred to
Oasis TM wedges
with their hypocotyls inserted in the wedges. Elongated shoots were separated
from the explant
and transferred to Oasis TM wedges for rooting. They were watered with a
solution that contains
1-3 pM lmazapyr once or twice a week. Rooted shoots were transferred to soil.
Leaf tissues
were collected and analyzed by Taqman TM assay for the presence of AHAS gene.
Plants were
grown to maturity in the greenhouse.
Experiment #Explants #Positive events Transformation
Efficiency (%)
A 87 6 6.9
B 81 5 6.17
C 125 3 2.4
